Latest Breaking News On - Medical oncology congress - Page 1 : comparemela.com

Whither CAR T? Will the FDA Being Under the Hood and the Availability of Bispecifics Make These Therapies Less Attractive?

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Fox-chase-cancer-center
Pennsylvania
United-states
Virginia
Philadelphia
Andrew-hertler
Garrick-wong
Amy-vangalder
Justin-tse
Seimetzd-catumaxomab
Oncologic-drugs-advisory-committee
National-cancer-institute

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Barcelona
Comunidad-autonoma-de-cataluna
Spain
Switzerland
Paris
France-general
France
Texas
United-states
Chicago
Illinois
Lugano

Bristol Myers Squibb's Opdivo approved by EC for adults with urothelial carcinoma

Bristol Myers Squibb's Opdivo approved by EC for adults with urothelial carcinoma
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

China
Japan
Dana-walker
Bristol-myers-squibb
European-society-of-medical-oncology-congress
European-commission
Drug-administration
Myers-squibb
European-society
Medical-oncology-congress

Wave of Antibody-Drug Conjugates Poised to Change Treatment Paradigms Across Multiple Cancers

Wave of Antibody-Drug Conjugates Poised to Change Treatment Paradigms Across Multiple Cancers
ajmc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajmc.com Daily Mail and Mail on Sunday newspapers.

San-francisco
California
United-states
Minnesota
Mayo-clinic-in-rochester
Singapore
Astellas-pharma
Ian-krop
Daiichi-sankyo-adcs
Bradley-mcgregor
Dana-farber-tarantino
Vadims-koshkin

AstraZeneca: positive trial in lung cancer

AstraZeneca reports that overall survival results from a Phase III trial favored datopotamab deruxtecan over docetaxel in patients with locally advanced or metastatic non-small cell lung cancer who.

Astrazeneca
European-society-of-medical-oncology-congress
Medical-oncology-congress